Concord Biotech Limited vs Lupin Limited Comparison
Auto-matched BRSR XBRL metric keys across selected companies.
Selected: 2 · Showing 250 rows
res.json())
.then(data => { results = data; open = true; highlight = -1; })
" @keydown.down.prevent="highlight = (highlight + 1) % results.length"
@keydown.up.prevent="highlight = (highlight - 1 + results.length) % results.length"
@keydown.enter.prevent="
if (highlight >= 0 && results[highlight]) {
window.location.href = 'https://simplyesg.com/compare/concord-biotech-limited-vs-lupin-limited-vs-' + results[highlight].slug;
}
" @focus="open = query.length >= 2">
Filter
Keys
277
common across selection
Keys
664
total union
Mode
Year: 2025
Common keys
| KPI | Concord Biotech Limited | Lupin Limited | Delta |
|---|---|---|---|
|
Environmental
Emissions
Air Emissions Other Than Ghg Emissions By The Entity Applicability
|
Yes | Yes | — |
|
Environmental
Energy
diff
Energy Consumption Through Other Sources From Non Renewable Sources
|
0 Non-SI:GJ | 370,895 Non-SI:GJ | +370895 Non-SI:GJ |
|
Environmental
Energy
Energy Consumption Through Other Sources From Renewable Sources
|
0 Non-SI:GJ | 0 Non-SI:GJ | 0 Non-SI:GJ |
|
Environmental
Energy
diff
Energy Intensity In Term Of Physical Output
|
2,734.33 Non-SI:GJ | 0 Non-SI:GJ | -2734.33 Non-SI:GJ (-100%) |
|
Environmental
Energy
Energy Intensity Per Rupee Of Turnover
|
0 Non-SI:GJ | 0 Non-SI:GJ | 0 Non-SI:GJ (-79%) |
|
Environmental
Energy
Energy Intensity Per Rupee Of Turnover Adjusting For Purchasing Power Parity
|
0 Non-SI:GJ | 0 Non-SI:GJ | 0 Non-SI:GJ (-76.7%) |
|
Environmental
Energy
diff
Total Electricity Consumption From Non Renewable Sources
|
300,866.84 Non-SI:GJ | 1,071,380 Non-SI:GJ | +770513.16 Non-SI:GJ (+256.1%) |
|
Environmental
Energy
diff
Total Electricity Consumption From Renewable Sources
|
0 Non-SI:GJ | 252,035 Non-SI:GJ | +252035 Non-SI:GJ |
|
Environmental
Energy
diff
Total Energy Consumed From Non Renewable Sources
|
977,838.45 Non-SI:GJ | 1,677,825 Non-SI:GJ | +699986.55 Non-SI:GJ (+71.6%) |
|
Environmental
Energy
diff
Total Energy Consumed From Renewable And Non Renewable Sources
|
977,838.45 Non-SI:GJ | 2,811,237 Non-SI:GJ | +1833398.55 Non-SI:GJ (+187.5%) |
|
Environmental
Energy
diff
Total Energy Consumed From Renewable Sources
|
0 Non-SI:GJ | 1,133,412 Non-SI:GJ | +1133412 Non-SI:GJ |
|
Environmental
Energy
diff
Any Independent Assessment Or Evaluation Or Assurance Has Been Carried Out By An External Agency For Energy Consumption Under Leadership Indicators
|
No | Yes | — |
|
Environmental
Energy
Total Energy Consumption And Energy Intensity Applicable To The Company
|
Yes | Yes | — |
|
Environmental
Other
Recycled
|
0 Non-SI:t | 0 Non-SI:t | 0 Non-SI:t |
|
Environmental
Other
Has The Entity Implemented Mechanism For Zero Liquid Discharge
|
Yes | Yes | — |
|
Environmental
Other
diff
Name Of Other Waste
|
Other waste-Spent solvent | Date Expired Products | — |
|
Environmental
Other
diff
Persistent Organic Pollutants
|
0 Non-SI:kg | 0 Non-SI:t | — |
|
Environmental
Other
diff
Total Fuel Consumption From Non Renewable Sources
|
676,971.61 Non-SI:GJ | 235,550 Non-SI:GJ | -441421.61 Non-SI:GJ (-65.2%) |
|
Environmental
Other
diff
Total Fuel Consumption From Renewable Sources
|
0 Non-SI:GJ | 881,377 Non-SI:GJ | +881377 Non-SI:GJ |
|
Environmental
Other
Processes For Workers To Report The Work Related Hazards And To Remove Themselves From Such Risks
|
Yes | Yes | — |
|
Environmental
Water
External assurance on water withdrawal (Yes/No)
|
Yes | Yes | — |
|
Environmental
Water
diff
Total Volume Of Water Consumption
|
385,410 kL | 1,664,260 kL | +1278850 kL (+331.8%) |
|
Environmental
Water
diff
Total Volume Of Water Withdrawal
|
385,410 kL | 1,704,375 kL | +1318965 kL (+342.2%) |
|
Environmental
Water
diff
Total Water Discharged In Kilolitres
|
253,167 kL | 40,115 kL | -213052 kL (-84.2%) |
|
Environmental
Water
diff
Water Discharge By Sent To Third Parties
|
0 kL | 40,115 kL | +40115 kL |
|
Environmental
Water
diff
Water Discharge By Sent To Third Parties With Treatment
|
0 kL | 40,115 kL | +40115 kL |
|
Environmental
Water
Water Discharge By Sent To Third Parties Without Treatment
|
0 kL | 0 kL | 0 kL |
|
Environmental
Water
diff
Water Discharge To Others
|
132,832 kL | 0 kL | -132832 kL (-100%) |
|
Environmental
Water
diff
Water Discharge To Others With Treatment
|
132,832 kL | 0 kL | -132832 kL (-100%) |
|
Environmental
Water
Water Discharge To Others Without Treatment
|
0 kL | 0 kL | 0 kL |
|
Environmental
Water
Water Discharge To Seawater
|
0 kL | 0 kL | 0 kL |
|
Environmental
Water
Water Discharge To Seawater With Out Treatment
|
0 kL | 0 kL | 0 kL |
|
Environmental
Water
Water Discharge To Seawater With Treatment
|
0 kL | 0 kL | 0 kL |
|
Environmental
Water
Water Intensity In Term Of Physical Output
|
0 kL | 0 kL | 0 kL (-100%) |
|
Environmental
Water
Water Intensity Per Rupee Of Turnover
|
0 kL | 0 kL | 0 kL (-68.8%) |
|
Environmental
Water
Water Intensity Per Rupee Of Turnover Adjusting For Purchasing Power Parity
|
0 kL | 0 kL | 0 kL (-65.2%) |
|
Environmental
Water
diff
Water Withdrawal By Groundwater
|
385,410 kL | 169,062 kL | -216348 kL (-56.1%) |
|
Environmental
Water
Water Withdrawal By Others
|
0 kL | 0 kL | 0 kL |
|
Environmental
Water
Water Withdrawal By Seawater Or Desalinated Water
|
0 kL | 0 kL | 0 kL |
|
Environmental
Water
diff
Water Withdrawal By Surface Water
|
0 kL | 140,892 kL | +140892 kL |
|
Environmental
Water
diff
Water Withdrawal By Third Party Water
|
0 kL | 1,394,421 kL | +1394421 kL |
|
Environmental
Water
diff
Water discharge to groundwater
|
120,335 kL | 0 kL | -120335 kL (-100%) |
|
Environmental
Water
diff
Water discharge to groundwater (treated)
|
96,938 kL | 0 kL | -96938 kL (-100%) |
|
Environmental
Water
diff
Water discharge to groundwater (untreated)
|
23,397 kL | 0 kL | -23397 kL (-100%) |
|
Environmental
Water
Water discharge to surface water
|
0 kL | 0 kL | 0 kL |
|
Environmental
Water
Water discharge to surface water (treated)
|
0 kL | 0 kL | 0 kL |
|
Environmental
Water
Water discharge to surface water (untreated)
|
0 kL | 0 kL | 0 kL |
|
Environmental
Water
diff
Any Independent Assessment Or Evaluation Or Assurance Has Been Carried Out By An External Agency For Water Discharged
|
No | Yes | — |
|
Governance
Governance
diff
Complaints On POSHUp Held
|
0 | 4 | +4 |
|
Governance
Governance
Complaints on directors conflict of interest (count)
|
0 | 0 | 0 |
|
Governance
Governance
diff
ABusiness Process Being Modified Or Introduced As AResult Of Addressing Human Rights Grievances Or Complaints
|
NA | Not Applicable, in the reporting year, there has been no business process or modifications. | — |
|
Governance
Governance
Directors with disciplinary actions (count)
|
0 | 0 | 0 |
|
Governance
Governance
Does The Entity Have ASpecified Committee Of The Board Or Director Responsible For Decision Making On Sustainability Related Issues
|
Yes | Yes | — |
|
Governance
Governance
Employees with disciplinary actions (count)
|
0 | 0 | 0 |
|
Governance
Governance
KMPs with disciplinary actions (count)
|
0 | 0 | 0 |
|
Governance
Governance
Median Of Remuneration Or Salary Or Wages Of Board Of Directors
|
₹ 0 | ₹ 0 | ₹ 0 |
|
Governance
Governance
Median Of Remuneration Or Salary Or Wages Of Employees Other Than Bod And KMP
|
₹ 0 | ₹ 0 | ₹ 0 |
|
Governance
Governance
# Board Of Directors For Remuneration Or Salary Or Wages
|
0 | 0 | 0 |
|
Governance
Governance
# Complaints Filed Year
|
0 | 0 | 0 |
|
Governance
Governance
diff
# Complaints Filed From Stake Holder Group Year
|
0 | 17 | +17 |
|
Governance
Governance
diff
# Complaints Pending From Stake Holder Group Resolution At The End Of Year
|
0 | 8 | +8 |
|
Governance
Governance
# Complaints Pending Resolution At The End Of Year
|
0 | 0 | 0 |
|
Governance
Governance
# Complaints Received In Relation To Issues Of Conflict Of Interest Of The KMPs
|
0 | 0 | 0 |
|
Governance
Governance
# Employees Other Than Bod And KMPFor Remuneration Or Salary Or Wages
|
0 | 0 | 0 |
|
Governance
Governance
diff
# Female Board Of Directors
|
1 | 3 | +2 (+200%) |
|
Governance
Governance
diff
% Complaints In Respect Of # Employees Or Worker
|
0 | 0.01 | +0.01 |
|
Governance
Governance
diff
% Female Board Of Directors
|
0.11 | 0.3 | +0.19 (+169.8%) |
|
Governance
Governance
diff
Remarks In Case Complaints Received In Relation To Issues Of Conflict Of Interest Of The Kmps
|
0 | Not Applicable | — |
|
Governance
Governance
diff
Remarks Stake Holder Group From Whom Complaint Is Received
|
0 | None | — |
|
Governance
Governance
diff
Remarks on directors conflict of interest complaints
|
0 | Not Applicable | — |
|
Governance
Governance
diff
Total Complaints Reported Under Sexual Harassment Of Women At Workplace
|
0 | 6 | +6 |
|
Governance
Governance
diff
Total # Board Of Directors
|
9 | 10 | +1 (+11.1%) |
|
Governance
Governance
Workers with disciplinary actions (count)
|
0 | 0 | 0 |
|
Governance
Other
diff
Compliance With Statutory Requirements Of Relevance To The Principles And Rectification Of Any Non Compliances Frequency
|
Quarterly | Annually | — |
|
Governance
Other
Compliance With Statutory Requirements Of Relevance To The Principles And Rectification Of Any Non Compliances Indicate Whether Review Was Undertaken By
|
Committee of the Board | Committee of the Board | — |
|
Governance
Other
Does The Entity Have An Anti Corruption Or Anti Bribery Policy
|
Yes | Yes | — |
|
Governance
Other
Does The Entity Have Processes In Place To Avoid Or Manage Conflict Of Interests Involving Members Of The Board
|
Yes | Yes | — |
|
Governance
Other
diff
Grievance Redressal Mechanism In Place
|
No | Yes | — |
|
Governance
Other
Has The Policy Been Approved By The Board
|
Yes | Yes | — |
|
Governance
Other
diff
Is There Mechanism Available To Receive And Redress Grievances For Other Than Permanent Employees
|
No | Yes | — |
|
Governance
Other
Is There Mechanism Available To Receive And Redress Grievances For Other Than Permanent Workers
|
Yes | Yes | — |
|
Governance
Other
Is There Mechanism Available To Receive And Redress Grievances For Permanent Employees
|
Yes | Yes | — |
|
Governance
Other
diff
Is There Mechanism Available To Receive And Redress Grievances For Permanent Workers
|
No | Yes | — |
|
Governance
Other
Is There Mechanism Available To Receive And Redress Grievances For The Following Categories Of Employees And Worker
|
Yes | Yes | — |
|
Governance
Other
diff
Web Link At Anti Corruption Or Anti Bribery Policy Is Place
|
https://www.concordbiotech.com/public/assets/pdf/anti-fraud-and-anti-corruption-policy.pdf | https://www.lupin.com/investors/code-of-conduct/ | — |
|
Governance
Other
diff
Web Link For Grievance Redress Policy
|
https:// www.concordbiotech. com/public/assets/pdf/ Concord-Biotech-Limited- Whistle-Blower-Policy.pdf. | None | — |
|
Governance
Other
diff
Company Has Undertaken Assessment Or Assurance Of The BRSRCore
|
No | Yes assurance | — |
|
Governance
Other
Waste Collection Plan Is In Line With The Extended Producer Responsibility Plan Submitted To Pollution Control Boards
|
Yes | Yes | — |
|
Other
Other
diff
Address Of Corporate Office
|
B-1601-1602, B-Wing, Mondeal Heights, Iskcon CrossRoad, S. G. Highway, Ahmedabad - 380015, Gujarat | Kalpataru Inspire, 3rd Floor, Off Western Express Highway, Santacruz (East), Mumbai - 400 055. India | — |
|
Other
Other
diff
Address Of Registered Office
|
1482-1486, Trasad Road, Dholka, Dist. Ahmedabad - 382225, Gujarat | Kalpataru Inspire, 3rd Floor, Off Western Express Highway, Santacruz (East), Mumbai - 400 055. India | — |
|
Other
Other
diff
Accounts Payable Year
|
₹ 4,125,953 | ₹ 7,212,254,000,000 | ₹ +7212249874047 (+174802036.6%) |
|
Other
Other
diff
Cost Incurred On Well Being Measures
|
₹ 20,066,000 | ₹ 105,334,400 | ₹ +85268400 (+424.9%) |
|
Other
Other
diff
Investments In Related Parties
|
₹ 0 | ₹ 3,938,000,000 | ₹ +3938000000 |
|
Other
Other
diff
Loans And Advances Given To Related Parties
|
₹ 0 | ₹ 1,550,000,000 | ₹ +1550000000 |
|
Other
Other
diff
Purchases From Related Parties
|
₹ 0 | ₹ 5,504,700,000 | ₹ +5504700000 |
|
Other
Other
diff
Purchases From Top Ten Trading Houses
|
₹ 105.48 | ₹ 3,980,000,000 | ₹ +3979999894.52 (+3773227052.1%) |
|
Other
Other
diff
Purchases From Trading Houses
|
₹ 160.83 | ₹ 6,534,600,000 | ₹ +6534599839.17 (+4063047838.8%) |
|
Other
Other
Re Used
|
0 Non-SI:t | 0 Non-SI:t | 0 Non-SI:t |
|
Other
Other
diff
Safely Disposed
|
602.23 Non-SI:t | 465 Non-SI:t | -137.23 Non-SI:t (-22.8%) |
|
Other
Other
diff
Sales To Dealers Or Distributors
|
₹ 167.59 | ₹ 665,591,100,000 | ₹ +665591099832.41 (+397154424388.3%) |
|
Other
Other
diff
Sales To Related Parties
|
₹ 30.35 | ₹ 66,499,200,000 | ₹ +66499199969.65 (+219107742898.4%) |
|
Other
Other
diff
Sales To Top Ten Dealers Or Distributors
|
₹ 80.73 | ₹ 36,262,134,847 | ₹ +36262134766.27 (+44917793591.3%) |
|
Other
Other
diff
Total Investments
|
₹ 6.09 | ₹ 4,043,600,000 | ₹ +4043599993.91 (+66397372642.2%) |
|
Other
Other
diff
Total Loans And Advances
|
₹ 0 | ₹ 1,628,400,000 | ₹ +1628400000 |
|
Other
Other
diff
Total Purchases
|
₹ 320.3 | ₹ 114,390,000,000 | ₹ +114389999679.7 (+35713393593.4%) |
|
Other
Other
diff
Total Purchases For Share Of Related Party Transactions
|
₹ 0 | ₹ 114,390,000,000 | ₹ +114390000000 |
|
Other
Other
diff
Total Purchases From Trading Houses
|
₹ 160.83 | ₹ 6,530,000,000 | ₹ +6529999839.17 (+4060187675.9%) |
|
Other
Other
diff
Total Sales
|
₹ 1,200.08 | ₹ 1,645,850,000,000 | ₹ +1645849998799.92 (+137145023565.1%) |
|
Other
Other
diff
Total Sales For Share Of Related Party Transactions
|
₹ 1,200.09 | ₹ 164,585,800,000 | ₹ +164585798799.91 (+13714454649.2%) |
|
Other
Other
diff
Total Sales To Dealers Or Distributors
|
₹ 167.59 | ₹ 665,591,100,000 | ₹ +665591099832.41 (+397154424388.3%) |
|
Other
Other
diff
Boundary For Which The Life Cycle Perspective Or Assessment Was Conducted
|
Manufacturing facility | Cradle to Grave | — |
|
Other
Other
diff
Category
|
Associate | Subsidiary | — |
|
Other
Other
Channels Of Communication
|
Other | Other | — |
|
Other
Other
diff
Contact # Contact Person
|
7,486,023,290 | +91 22 6640 2323 | — |
|
Other
Other
diff
Corporate Identity Number
|
L24230GJ1984PLC007440 | L24100MH1983PLC029442 | — |
|
Other
Other
diff
Cost Of Goods Or Services Procured Year
|
₹ 30,551.31 | ₹ 108,840,000,000 | ₹ +108839969448.69 (+356253036.1%) |
|
Other
Other
Date Of End Of FY
|
2025-03-31 | 2025-03-31 | — |
|
Other
Other
Date Of End Of Previous Year
|
2024-03-31 | 2024-03-31 | — |
|
Other
Other
Date Of End Of Prior To Previous Year
|
2023-03-31 | 2023-03-31 | — |
|
Other
Other
diff
Date Of Incorporation
|
1984-09-23 | 1983-03-01 | — |
|
Other
Other
Date Of Start Of FY
|
2024-04-01 | 2024-04-01 | — |
|
Other
Other
Date Of Start Of Previous Year
|
2023-04-01 | 2023-04-01 | — |
|
Other
Other
Date Of Start Of Prior To Previous Year
|
2022-04-01 | 2022-04-01 | — |
|
Other
Other
Deducted And Deposited With The Authority
|
Yes | Yes | — |
|
Other
Other
diff
Description Of Business Activity
|
Research, development, manufacturing and sale of finished formulations | Manufacturing and sales of pharmaceuticals | — |
|
Other
Other
diff
Description Of Main Activity
|
Manufacturing of pharmaceuticals | Manufacture of Pharmaceuticals | — |
|
Other
Other
diff
Any Corrective Actions Taken Or Underway To Address Significant Risks Or Concerns Arising From The Assessments Of Plant And Office
|
NA | Tier 1 Strategic suppliers identified by Procurement teams, are sensitized and trained on the Lupin’s Human Rights Policy in FY25. | — |
|
Other
Other
diff
Any Corrective Actions Taken Or Underway To Address Significant Risks Or Concerns Arising From The Assessments Of Value Chain Partner
|
NA | Not Applicable, no major risks were identified as a part of the assessment. | — |
|
Other
Other
diff
Improvements In Environmental And Social Impacts Due To Capex
|
Expenditure in ETP | For details on environmental and social benefits driven by the company, please refer to chapters Intellectual Capital, Social Capital and Natural Capital in the... | — |
|
Other
Other
diff
Improvements In Environmental And Social Impacts Due To RAnd D
|
NA | For details on environmental and social benefits driven by the company, please refer to chapters Intellectual Capital, Social Capital and Natural Capital in the... | — |
|
Other
Other
diff
Other Channels Of Communication
|
Review meets, festive events, welfare events, out bound training programmes, e-mails, website, notice boards, meetings, one-on-one discussions, and townhalls | Personal Meetings, Focused Group Discussions, Field Visits by CSR Team, trainings and capacity building sessions | — |
|
Other
Other
diff
Other Frequency Of Engagement
|
Ongoing and needbased | Frequent and need-based | — |
|
Other
Other
diff
Highest Authority Responsible For Implementation And Oversight Of The Business Responsibility Policy
|
The Chairman, the Chief Executive Officer and the KMPs broadly manage the Business Responsibility (BR) policies. | Ramesh Swaminathan, Executive Director, Global CFO, Head of IT and API Plus SBU | — |
|
Other
Other
Do Human Rights Requirements Form Part Of Your Business Agreements And Contracts
|
Yes | Yes | — |
|
Other
Other
Do The Enlisted Policies Extend To Your Value Chain Partners
|
Yes | Yes | — |
|
Other
Other
Do You Have AFocal Point Responsible For Addressing Human Rights Impacts Or Issues Caused Or Contributed To By The Business
|
Yes | Yes | — |
|
Other
Other
Does Company Participate In The Business Responsibility Initiatives Of The Listed Entity
|
No | No | — |
|
Other
Other
Does The Entity Have An Equal Opportunity Policy As Per The Rights Of Persons With Disabilities Act 2016
|
Yes | Yes | — |
|
Other
Other
Does The Entity Have Procedures In Place For Sustainable Sourcing
|
Yes | Yes | — |
|
Other
Other
Does The Entity Provide Transition Assistance Programs To Facilitate Continued Employability And The Management Of Career Endings Resulting From Retirement Or Termination Of Employment
|
No | No | — |
|
Other
Other
diff
EMail Of Contact Person
|
lalitsethi@concordbiotech.com | hosecretarial@lupin.com | — |
|
Other
Other
diff
EMail
|
lalitsethi@concordbiotech.com | hosecretarial@lupin.com | — |
|
Other
Other
diff
Financial Implications Of The Risk Or Opportunity
|
Negative Implications | Positive Implications | — |
|
Other
Other
Frequency Of Engagement
|
Others – please specify | Others – please specify | — |
|
Other
Other
diff
Gross Wages Paid To Female
|
₹ 3,571,359 | ₹ 1,271,959,508 | ₹ +1268388149 (+35515.6%) |
|
Other
Other
diff
Has The Entity Carried Out Independent Assessment Evaluation Of The Working Of Its Policies By An External Agency
|
No | Yes | — |
|
Other
Other
Has The Entity Conducted Life Cycle Perspective Or Assessments For Any Of Its Products Or For Its Services
|
Yes | Yes | — |
|
Other
Other
diff
In Case Of Risk Approach To Adapt Or Mitigate
|
•Complying with regulatory requirements for waste management • Ensuring responsible treatment of generated waste • Implementing proper methods for waste disposa... | NA | — |
|
Other
Other
diff
Indicate Whether Risk Or Opportunity
|
R | O | — |
|
Other
Other
Is The Premise Or Office Accessible To Differently Abled Visitors As Per The Requirements Of The Rights Of Persons With Disabilities Act 2016
|
Yes | Yes | — |
|
Other
Other
diff
Material Issue Identified
|
Waste management Risk | Risk Management and Business Continuity | — |
|
Other
Other
Median Of Remuneration Or Salary Or Wages Of Key Managerial Personnel
|
₹ 0 | ₹ 0 | ₹ 0 |
|
Other
Other
diff
NICCode Of Product Or Service Of Conducted Lifecycle Perspective
|
21,002 | 24,232 | +3230 (+15.4%) |
|
Other
Other
NICCode Of Product Or Service Sold By The Entity
|
210 | 210 | 0 (0%) |
|
Other
Other
diff
NOx
|
2,068.87 Non-SI:kg | 145.8 Non-SI:t | — |
|
Other
Other
diff
Name Of Contact Person
|
Mr. Lalit Sethi | Ramesh Swaminathan | — |
|
Other
Other
diff
Name Of Product Or Service Of Conducted Lifecycle Perspective
|
Formulation | Budamate (inhaler) | — |
|
Other
Other
diff
Name Of Stock Exchange Where The Company Is Listed
|
BSE | NSE | — |
|
Other
Other
diff
Name
|
Concord Biotech Limited | Lupin Limited | — |
|
Other
Other
diff
Name Of The Holding Or Subsidiary Associate Companies Or Joint Ventures
|
Clean Max Everglades Private Limited | Lupin Philippines Inc, Philippines | — |
|
Other
Other
diff
Name Of The National And International Codes Or Certifications Or Labels Or Standards Adopted By Your Entity And Mapped To Each Principle
|
USFDA EUGMP PMDA, Japan MDFS, Korea, ANVISA (Brazil) GMP certificate | NGRBC | — |
|
Other
Other
diff
Net Worth
|
₹ 18,126,462,204 | ₹ 243,079,098,682 | ₹ +224952636478 (+1241%) |
|
Other
Other
diff
# Countries Where Market Served By The Entity
|
75 | 112 | +37 (+49.3%) |
|
Other
Other
diff
# Days Of Accounts Payable
|
P135D | P66D | — |
|
Other
Other
diff
# Dealers Or Distributors To Whom Sales Are Made
|
367 | 7,661 | +7294 (+1987.5%) |
|
Other
Other
diff
# Female Key Management Personnel
|
0 | 1 | +1 |
|
Other
Other
# Key Managerial Personnel For Remuneration Or Salary Or Wages
|
0 | 0 | 0 |
|
Other
Other
diff
# Locations
|
0 | 10 | +10 |
|
Other
Other
# States Where Market Served By The Entity
|
28 | 28 | 0 (0%) |
|
Other
Other
diff
# Trading Houses Where Purchases Are Made
|
137 | 232 | +95 (+69.3%) |
|
Other
Other
diff
Particulate Matter
|
1,675.6 Non-SI:kg | 0 Non-SI:t | — |
|
Other
Other
diff
% Capex
|
0 | 0.08 | +0.07 (+18650%) |
|
Other
Other
diff
% Child Labour Of Value Chain Partners P 5
|
0 | 1 | +1 |
|
Other
Other
% Child Labour Of Your Plants And Offices That Were Assessed P 5
|
1 | 1 | 0 (0%) |
|
Other
Other
% Cost Incurred On Well Being Measures With Respect To Total Revenue
|
0 | 0 | 0 (-64.7%) |
|
Other
Other
diff
% Discrimination At Work Place Of Value Chain Partners P 5
|
0 | 1 | +1 |
|
Other
Other
% Discrimination At Work Place Of Your Plants And Offices That Were Assessed P 5
|
1 | 1 | 0 (0%) |
|
Other
Other
diff
% Female Key Management Personnel
|
0 | 0.25 | +0.25 |
|
Other
Other
diff
% Forced Labour Or Involuntary Labour Of Value Chain Partners P 5
|
0 | 1 | +1 |
|
Other
Other
% Forced Labour Or Involuntary Labour Of Your Plants And Offices That Were Assessed P 5
|
1 | 1 | 0 (0%) |
|
Other
Other
diff
% Gross Wages Paid To Female To Total Wages Paid
|
0.02 | 0.07 | +0.05 (+343.7%) |
|
Other
Other
% Inputs Were Sourced Sustainably
|
1 | 1 | 0 (0%) |
|
Other
Other
diff
% Investments In Related Parties In Total Investments
|
0 | 0.97 | +0.97 |
|
Other
Other
% Persons In Respective Category Covered By The Awareness Programmes
|
1 | 1 | 0 (0%) |
|
Other
Other
diff
% Purchases From Top Ten Trading Houses In Total Purchases From Trading Houses
|
0.66 | 0.61 | -0.05 (-7.1%) |
|
Other
Other
diff
% Purchases From Trading Houses In Total Purchases For Concentration Of Purchases
|
0.5 | 0.06 | -0.45 (-88.6%) |
|
Other
Other
diff
% RAnd D
|
0 | 1 | +1 |
|
Other
Other
diff
% Sales To Dealers Or Distributors In Total Sales
|
0.14 | 0.4 | +0.26 (+189.7%) |
|
Other
Other
diff
% Sales To Related Parties In Total Sales For Share Of Related Party Transactions
|
0.03 | 0.4 | +0.38 (+1496.8%) |
|
Other
Other
diff
% Sales To Top Ten Dealers Or Distributors In Total Sales To Dealers Or Distributors
|
0.48 | 0.05 | -0.43 (-88.7%) |
|
Other
Other
diff
% Shares Held By Listed Entity
|
0.26 | 1 | +0.74 (+284.6%) |
|
Other
Other
diff
% Value Chain Partners Covered Under The Awareness Programmes
|
0.8 | 1 | +0.2 (+25%) |
|
Other
Other
diff
% Wages Of Value Chain Partners P 5
|
0 | 1 | +1 |
|
Other
Other
% Wages Of Your Plants And Offices That Were Assessed P 5
|
1 | 1 | 0 (0%) |
|
Other
Other
diff
% Working Conditions Of Value Chain Partners P 3
|
0 | 1 | +1 |
|
Other
Other
% Working Conditions Of Your Plants And Offices That Were Assessed P 3
|
1 | 1 | 0 (0%) |
|
Other
Other
diff
Performance Against Above Policies And Follow Up Action Frequency
|
Annually | Half Yearly | — |
|
Other
Other
Performance Against Above Policies And Follow Up Action Indicate Whether Review Was Undertaken By
|
Committee of the Board | Committee of the Board | — |
|
Other
Other
diff
Product Or Service Sold By The Entity
|
Formulations | Manufacture of Pharmaceuticals | — |
|
Other
Other
diff
Purpose And Scope Of Engagement Including Key Topics And Concerns Raised During Such Engagement
|
Concord engages with healthcare professionals to keep them informed about its products and innovations, with key areas of focus being product quality and availa... | Engage on Lupin's products, innovations, healthcare solutions, patient needs, and ethical marketing commitment. | — |
|
Other
Other
diff
Rationale For Identifying The Risk Opportunity
|
Data breaches, along with unauthorised access to intellectual property and R&D data, can pose serious threats to Concord’s operations. | We face inherent challenges in managing our diverse portfolio of drug products across multiple international generic markets, which are highly competitive. | — |
|
Other
Other
Reporting Boundary
|
Standalone basis | Standalone basis | — |
|
Other
Other
Results Communicated In Public Domain
|
No | No | — |
|
Other
Other
diff
Revenue From Operations
|
₹ 12,000,868,947 | ₹ 164,585,800,000 | ₹ +152584931053 (+1271.4%) |
|
Other
Other
diff
SOx
|
1,077.36 Non-SI:kg | 50.1 Non-SI:t | — |
|
Other
Other
diff
Stakeholder Group
|
Employees | Communities and NGOS | — |
|
Other
Other
diff
Telephone
|
7,486,023,290 | + 91 22 6640 2323 | — |
|
Other
Other
diff
Total # Awareness Programmes Held
|
5 | 8 | +3 (+60%) |
|
Other
Other
Total # Key Management Personnel
|
4 | 4 | 0 (0%) |
|
Other
Other
diff
Total Revenue
|
₹ 12,000,868,947 | ₹ 164,585,000,000 | ₹ +152584131053 (+1271.4%) |
|
Other
Other
diff
Total Wages Paid
|
₹ 222,740,000 | ₹ 17,916,629,090 | ₹ +17693889090 (+7943.7%) |
|
Other
Other
diff
Value Of Shares Paid Up
|
₹ 104,616,204 | ₹ 913,130,090 | ₹ +808513886 (+772.8%) |
|
Other
Other
diff
Volatile Organic Compounds
|
0 Non-SI:kg | 0 Non-SI:t | — |
|
Other
Other
diff
Web Link Of The Policies
|
NA | https://www.lupin.com/wp-content/uploads/2025/05/ethical-marketing-policy.pdf https://www.lupin.com/wp-content/uploads/2025/04/information-security-management-s... | — |
|
Other
Other
diff
Website
|
www.concordbiotech.com | www.lupin.com | — |
|
Other
Other
diff
Conducted By Independent External Agency
|
No | Yes | — |
|
Other
Other
Extended Producer Responsibility Is Applicable To The Entity SActivities
|
Yes | Yes | — |
|
Other
Other
diff
Identified As Vulnerable And Marginalized Group
|
No | Yes | — |
|
Other
Other
Stakeholder Consultation Is Used To Support The Identification And Management Of Environmental And Social Topics
|
Yes | Yes | — |
|
Other
Other
Entity Has Translated The Policy Into Procedures
|
Yes | Yes | — |
|
Other
Other
Policies Cover Each Principle And Its Core Elements Of The NGRBCs
|
Yes | Yes | — |
|
Social
Other
diff
Are The Premises Or Offices Accessible To Differently Abled Employees And Workers
|
No | Yes | — |
|
Social
Other
diff
Average # Female Employees Or Workers At The Beginning Of The Year And As At End Of The Year
|
113 | 1,179 | +1066 (+943.4%) |
|
Social
Other
diff
Any Corrective Action Taken Or Underway To Address Safety Related Incidents On Assessment Of Value Chain Partners
|
NA. Vendor qualification processes, including both physical and virtual audits, form an essential part of the Quality Assurance department’s oversight for our k... | Not Applicable | — |
|
Social
Other
Do The Employees Or Worker Have Access To Non Occupational Medical And Healthcare Services
|
Yes | Yes | — |
|
Social
Other
Does The Entity Extend Any Life Insurance Or Any Compensatory Package In The Event Of Death Of Employees
|
Yes | Yes | — |
|
Social
Other
Does The Entity Extend Any Life Insurance Or Any Compensatory Package In The Event Of Death Of Workers
|
Yes | Yes | — |
|
Social
Other
Does The Entity Have Any Sites Or Facilities Identified As Designated Consumers Under The Performance Achieve And Trade Scheme Of The Government Of India
|
No | No | — |
|
Social
Other
High Consequence Work Related Injury Or Ill Health Excluding Fatalities
|
0 | 0 | 0 |
|
Social
Other
diff
Lost Time Injury Frequency Rate Per One Million Person Hours Worked
|
0 | 0.09 | +0.09 |
|
Social
Other
Median Of Remuneration Or Salary Or Wages Of Workers
|
₹ 0 | ₹ 0 | ₹ 0 |
|
Social
Other
# Differently Abled Employees Or Workers
|
0 | 0 | 0 |
|
Social
Other
diff
# Employees Covered As % Total Employees
|
0 | 0.03 | +0.03 |
|
Social
Other
# Employees Covered As % Total Worker
|
0 | 0 | 0 |
|
Social
Other
# Employees Or Whose Family Members Rehabilitated And Placed In Suitable Employment
|
0 | 0 | 0 |
|
Social
Other
# Employees Or Worker For Performance And Career Development
|
0 | 0 | 0 |
|
Social
Other
# Employees Or Workers Are Part Of Associations Or Union
|
0 | 0 | 0 |
|
Social
Other
diff
# Employees Or Workers Covered For Provided Training On Human Rights Issues
|
0 | 1,338 | +1338 |
|
Social
Other
# Employees Or Workers Including Differently Abled
|
0 | 0 | 0 |
|
Social
Other
# Employees Or Workers Related To Minimum Wages
|
0 | 0 | 0 |
|
Social
Other
diff
# Fatalities
|
0 | 1 | +1 |
|
Social
Other
# Trained Employees Or Workers
|
0 | 0 | 0 |
|
Social
Other
# Well Being Of Employees Or Workers
|
0 | 0 | 0 |
|
Social
Other
# Workers For Remuneration Or Salary Or Wages
|
0 | 0 | 0 |
|
Social
Other
# Workers Or Whose Family Members Rehabilitated And Placed In Suitable Employment
|
0 | 0 | 0 |
|
Social
Other
diff
% Contribution Of Exports In The Total Turnover
|
0.45 | 0.54 | +0.09 (+19.8%) |
|
Social
Other
% Differently Abled Employees Or Workers
|
0 | 0 | 0 |
|
Social
Other
% Employees Or Worker For Performance And Career Development
|
0 | 0 | 0 |
|
Social
Other
% Employees Or Workers Are Part Of Associations Or Union Of Total # Employee
|
0 | 0 | 0 |
|
Social
Other
diff
% Employees Or Workers Covered For Provided Training On Human Rights Issues
|
0 | 0.75 | +0.75 |